Loperamide hydrochloride
SIGMA/L4762
Synonym: 4-(p-
CAS Number: 34552-83-5
Empirical Formula (Hill Notation): C29H33ClN2O2 · HCl
Molecular Weight: 513.50
EC Number: 252-082-4
MDL Number: MFCD00058581
Linear Formula: C29H33ClN2O2 · HCl
Product Type: Chemical
| InChI | 1S/C29H33ClN2O2.ClH/c1-31 |
| InChI key | PGYPOBZJRVSMDS-UHFFFAOYSA |
| originator | Johnson & Johnson |
| Quality Level | 200 ![]() |
| SMILES string | Cl.CN(C)C(=O)C(CCN1CCC(O) |
| Application: | Loperamide hydrochloride (HCl) has been used in inflammatory pain experiments and to assess the functionality of proteins. 54 |
| Biochem/physiol Actions: | Loperamide hydrochloride (HCl) is a non-selective Ca2+ channel blocker. At nanomolar concentrations, it binds to μ-opioid receptors. Loperamide HCl does not cross the blood-brain barrier. |
| Features and Benefits: | This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Preparation Note: | Slightly soluble in water and dilute acids, freely soluble in methanol and in chloroform, soluble in ethanol (95%). |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P264 - P270 - P301 + P310 + P330 - P405 - P501 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| UNSPSC | 12352200 |


